[HTML][HTML] Mitochondrial diseases: hope for the future

OM Russell, GS Gorman, RN Lightowlers, DM Turnbull - Cell, 2020 - cell.com
Mitochondrial diseases are clinically heterogeneous disorders caused by a wide spectrum
of mutations in genes encoded by either the nuclear or the mitochondrial genome …

Mitochondrial disease in adults: recent advances and future promise

YS Ng, LA Bindoff, GS Gorman, T Klopstock… - The Lancet …, 2021 - thelancet.com
Mitochondrial diseases are some of the most common inherited neurometabolic disorders,
and major progress has been made in our understanding, diagnosis, and treatment of these …

Thymidine nucleotide metabolism controls human telomere length

W Mannherz, S Agarwal - Nature genetics, 2023 - nature.com
Telomere length in humans is associated with lifespan and severe diseases, yet the genetic
determinants of telomere length remain incompletely defined. Here we performed genome …

Mitochondrial disease in children

S Rahman - Journal of internal medicine, 2020 - Wiley Online Library
Mitochondrial disease presenting in childhood is characterized by clinical, biochemical and
genetic complexity. Some children are affected by canonical syndromes, but the majority …

Clinical trials in mitochondrial disorders, an update

M Almannai, AW El-Hattab, M Ali… - Molecular genetics and …, 2020 - Elsevier
Mitochondrial disorders comprise a molecular and clinically diverse group of diseases that
are associated with mitochondrial dysfunction leading to multi-organ disease. With recent …

The Finnish genetic heritage in 2022–from diagnosis to translational research

J Uusimaa, J Kettunen, T Varilo… - Disease Models & …, 2022 - journals.biologists.com
Isolated populations have been valuable for the discovery of rare monogenic diseases and
their causative genetic variants. Finnish disease heritage (FDH) is an example of a group of …

Strategies for fighting mitochondrial diseases

C Viscomi, M Zeviani - Journal of internal medicine, 2020 - Wiley Online Library
Mitochondrial diseases are extremely heterogeneous genetic conditions characterized by
faulty oxidative phosphorylation (OXPHOS). OXPHOS deficiency can be the result of …

Therapeutic approaches to treat mitochondrial diseases:“one-size-fits-all” and “precision medicine” strategies

E Bottani, C Lamperti, A Prigione, V Tiranti, N Persico… - Pharmaceutics, 2020 - mdpi.com
Primary mitochondrial diseases (PMD) refer to a group of severe, often inherited genetic
conditions due to mutations in the mitochondrial genome or in the nuclear genes encoding …

Endocrine manifestations and new developments in mitochondrial disease

YS Ng, AZ Lim, G Panagiotou, DM Turnbull… - Endocrine …, 2022 - academic.oup.com
Mitochondrial diseases are a group of common inherited diseases causing disruption of
oxidative phosphorylation. Some patients with mitochondrial disease have endocrine …

Multicenter consensus approach to evaluation of neonatal hypotonia in the genomic era: a review

SU Morton, J Christodoulou, G Costain… - JAMA …, 2022 - jamanetwork.com
Importance Infants with hypotonia can present with a variety of potentially severe clinical
signs and symptoms and often require invasive testing and multiple procedures. The wide …